[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website
Drugs at FDA: FDA Approved Drug Products. Links to Initial Search Page FAQ  |  Instructions  |  Glossary  |  Contact Us  |  CDER Home 
Start Over (Drugs@FDA Home)

Overview
Drug Name CYMBALTA
Active Ingredient(s) • DULOXETINE HYDROCHLORIDE
Form(s) and
Strength(s) Available		 • CAPSULE, DELAYED REL PELLETS; ORAL: EQ 20MG BASE; EQ 30MG BASE; EQ 40MG BASE; EQ 60MG BASE
• CAPSULE, DELAYED RELEASE; ORAL: 60MG

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

Click on a drug name or application number to view drug details:
    Click on a column header to re-sort the table:

Drug Name and
FDA Application
Number
Dosage Form/Route
Strength
Marketing Status
Company
CYMBALTA
(NDA # 021427)		 CAPSULE, DELAYED REL PELLETS; ORAL  Multiple Strengths  Prescription LILLY
CYMBALTA
(NDA # 021733)		 CAPSULE, DELAYED REL PELLETS; ORAL  Multiple Strengths  Prescription LILLY
CYMBALTA
(NDA # 022148)		 CAPSULE, DELAYED RELEASE; ORAL  60MG  Prescription ELI LILLY

Back to Top | Back to Previous Page | Back to Drugs@FDA Home

Disclaimer
CDER Home Page | Contact CDER | What's New @ CDER
FDA Home Page | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
Office of Training and Communications
Division of Information Services
Update Frequency: Daily